23-25 January, 2017
London, UK

Media Center

Featured Download

PDFPDF

  • Maximising ROI Within Clinical Trial SupplyMaximising ROI Within Clinical Trial Supply
    With the help of industry experts, this Pharma IQ infographic highlights key methods to maximise returns within clinical trial supply.

    Download the infographic below. 
  • Innovation in Clinical Trial SupplyInnovation in Clinical Trial Supply
    Innovation is thought to be a keystone in the process of being competitive in any market. Within clinical trial supply, a lack of innovation can be costly in regards to a range of variables.

    With this in mind, Pharma IQ discusses the latest trailblazing techniques in the arena with a panel of Clinical Trial Supply specialists.
  • Planning & Forecasting Considerations in Global Clinical Trial SupplyPlanning & Forecasting Considerations in Global Clinical Trial Supply
    Often orchestrated on a global scale, clinical trials require the production and distribution of the investigational pharmaceuticals to thousands of participants over several years. 

    Here, Clinical Trial Supply Europe presents the results of its 2016 Report focused on the realms of planning and forecasting supply within global clinical trials. 

  • CTS 2016 - Exhibition Floor PlanCTS 2016 - Exhibition Floor Plan
    Download the latest floor plan for CTS Europe 2016. To find out how you can get involved join the the industries leading brands at Clinical Trial Supply Europe 2016 email sponsorship@iqpc.co.uk or call us on +44 (0)207 268 9300.

Top FeaturedTop Featured

  • The Future of Clinical Trial Supply – Trends and Challenges 2015 ReportThe Future of Clinical Trial Supply – Trends and Challenges 2015 Report

    To discover the driving trends and priorities in clinical trial supply, Pharma IQ recently conducted the Clinical Trial Supply Outlook 2015. This collected information and opinions from a diverse array of clinical trials professionals to take the pulse of this changing area. In this report, we gather these responses as well as expert insight on the findings along with interviews with thought leaders and articles on key trends to give you an in depth look at the current state of clinical trial supply

Additional Content Download

Interviews

  • Minimising Wastage in Time and MoneyMinimising Wastage in Time and Money
    The operation of clinical trials are integral to the progression of the pharmaceutical industry. These trials can be orchestrated on a global scale, producing and distributing the drug in question to participants over several years.

    Therefore, the supply of these trials represents one of the biggest challenges to be navigated. Undoubtedly, the efficient management of clinical trial supply entails regulating two dominant variables: Time and money. 

Top Featured

  • Clinical Trial Supply Infographic: Facing Clinical Trial Supply ChallengesClinical Trial Supply Infographic: Facing Clinical Trial Supply Challenges
    45.5% of clinical trial supply professionals consider Brazil to be the most challenging market to work in

    Did you know that more than 52% of clinical trials professionals express a high interest in labelling standardisation? We did. The Clinical Trial Supply Europe Conference is now five years old and we at Pharma IQ wanted to hear from the community what their challenges and priorities in this area are. We ran the Clinical Trial Supply Outlook 2015 Survey through July and August. Our community of Clinical Trials professionals let us know the latest from this changing field.

  • Clinical Trials Supply Industry Report 2013
    A thorough report on the best practices to:
    • Reduce overage through implementing product pooling and just in time labelling with strategies from our expert advisory panel
    • Leverage outsourcing opportunities by learning best practice in distribution and logistics
    • Get to grips with GDP regulations to understand the latest requirements for controlled room temperature

Video

Podcasts

  • Clinical Trial Supply Case Study: Bial - An Interview with Ricardo Lima

    Smaller companies face differing challenges in Clinical Trial Supply, but they also have their own unique advantages. We spoke to Ricardo Lima, Head of Pharmaceutical Development at Bial Research & Development about Bial's experiences.He discussses comparator sourcing, forecasting and working in emerging markets in this detailed case study of Clinical Trial Supply at Bial.

  • Optimising Your Clinical Supply ChainOptimising Your Clinical Supply Chain
    Mark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for logistics in emerging countries. He also talks about the need for pharmaceutical and biotech companies to optimise logistics and overcome inefficiencies in the clinical supply chain.
  • Site Perspectives on Clinical Trial Supply- An Interview with Samantha CarmichaelSite Perspectives on Clinical Trial Supply- An Interview with Samantha Carmichael

    Should companies be communicating more clearly with their site teams with regard to their expectations? We spoke to Samantha Carmichael, Lead Pharmacist Clinical Trials at NHS Greater Glasgow & Clyde to gain insight into challenges for sites from the different stages in clinical supply management.

  • Logistics for Clinical Trials in Emerging MarketsLogistics for Clinical Trials in Emerging Markets

    Mark Walls, Director of Clinical Pharmacy at Human Genome Sciences, speaks to Andrea Charles from Pharma IQ, about the logistical challenges facing clinical trials and avoiding common mistakes for logistics in emerging countries. He also talks about the need for pharmaceutical and biotech companies to optimise logistics and overcome inefficiencies in the clinical supply chain.   

  • Has the Balance of Power Shifted Along the Clinical Supply Chain?Has the Balance of Power Shifted Along the Clinical Supply Chain?

    Steven A. Jacobs, President, Global BioPharm Solutions, shares his insights with Andrea Charles from Pharma IQ, about the paradigm shift in pharma and how this will this directly affect the clinical trial supply area. Jacobs also speaks about the movement of clinical trial supply towards a solely virtual model and how the balance of power is shifting along the clinical supply chain. To conclude, Jacobs predicts what  technologies and strategies we can expect to see on the horizon. 

  • Celebrating International Clinical Trials Day: Starting with the Supply Chain by Niamh MadiganCelebrating International Clinical Trials Day: Starting with the Supply Chain by Niamh Madigan

    International Clinical Trials' Day will be celebrated on the 20th of May in order to celebrate the day that James Lind started his famous trial on the 20th of May 1747. In a series of interviews to celebrate this date, Pharma IQ spoke to Robert Smith, Clinical Trials Expert, to gain a picture of current trends in Clinical Trials, and asked how Clinical Trials Supply could specifically be improved to ensure the efficiency of Clinical Trials today.

  • Forecasting a Brighter Future for Clinical Trial Supply in Emerging Markets- An Interview with Adrian PeskettForecasting a Brighter Future for Clinical Trial Supply in Emerging Markets- An Interview with Adrian Peskett

    Pharma IQ interviewed Adrian Peskett, Clinical Supply Logistics Director at Pfizer Ltd. about his predictions for the future of clinical trial supply in emerging markets. Adrian also speaks about the importance of forecasting in emerging markets and the difficulties in standardising strategy, while meeting countries' individual needs.

Articles

  • The Growing Diversity Between SME Biotech Business Models
    As with most sectors, the biotechnology industry is driven by the innovative vigor of small or medium-sized enterprises (SMEs). Most biotechnology SMEs grow slowly and depend on limited financial opportunities from external sources. However, the lack of resources in larger companies and fundamental problems in the models of business prevent most SMEs from succeeding. Competition from larger companies and the lack of marketing capabilities have also battered many opportunities for SMEs. There are three major factors that contribute to the restriction of growth of biotech SMEs: Complicated patenting and costly regulatory systems. Insufficient risk capital for early-stage development. The incongruous marriage between science and business. It is crucial for all new and existing biotech companies to take these three factors into their business model. The key implications of SME research and development depend on the dynamic business models, i.e. a fluid construct model instead of concrete
  • Genzyme China: 3 Top Tips for Effective Clinical OperationsGenzyme China: 3 Top Tips for Effective Clinical Operations
    With more clinical trials being held in China than ever before, clinical trial supply systems need to become increasingly sophisticated in order to cope with local regulations, importation and exportation guidelines, application of licenses, transit, packaging and labeling requirements, temperature-controlled storage and transportation and local distribution. In this quickfire Q&A we speak with Wang Tao, Head of Clinical Operations at Genzyme, about the the clinical trial supply issues faced by the pharmaceutical industry in China.
  • Top 10 Statistics From Pharma IQTop 10 Statistics From Pharma IQ's Clinical Trial Supply Survey
    The latest results from Pharma IQ’s survey of industry  professionals highlights that running clinical trials in emerging market (e.g. BRIC) nations remains a firm priority for companies actively perusing research. The survey carried out the research team here at Pharma IQ in April has revealed many of the most important trends within Clinical Trial Supply and it suggests many reasons to be optimistic.
  • The Clinical Trials ProcessThe Clinical Trials Process
    What are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out!   Clinical trials play an extremely important role in helping pharmaceutical companies get their products to market. They are designed to ensure the safety and efficacy of new products before they are marketed to the public and they are needed for companies to be granted a licence for their drugs. Approval has to be sought by the regulatory authorities in the individual countries where the pharmaceutical clinical trials are being conducted before they can begin. In the United States, this is the Food and Drugs Administration, while in the UK, the Clinical Trials unit of the Medicines and Healthcare Products Regulatory Authority is tasked with the responsibility. Pharmaceutical clinical trials can be carried out either in-house or by clinical research organisations (CRO), which are also sometimes known as contract research organisations. The Association of
  • Talking Heads: 7 Growing Trends in Clinical Trial SupplyTalking Heads: 7 Growing Trends in Clinical Trial Supply

    Pharma IQ had a quick ring around with some of our trusted experts who are working in clinical trials to get an overview on current and emerging trends in clinical trial supply. This panel of experts included, Robert Bronstein, Director - Clinical Supply Operations, MacroGenics; Robert Smith, Clinical Trials Expert and Steven A. Jacobs, MBA, R.Ph.President, Global BioPharm Solutions, LLC.

  • Site Perspectives on Clinical Trial Supply- Samantha CarmichaelSite Perspectives on Clinical Trial Supply- Samantha Carmichael
    Samantha Carmichael Lead Pharmacist Clinical Trials NHS Greater Glasgow & Clyde Samantha Carmichael has 18 years experience as a pharmacist, having spent time in many different areas of pharmacy, including hospital pharmacy and within the private sector working for a large international pharmaceutical company.  She is currently the Lead Pharmacist for Clinical Trials and one of the Lead Sponsor Representatives within NHS Greater Glasgow & Clyde Healthboard. NHS GGC is the largest healthboard in the UK, providing healthcare services to a population of 1.2 million in the West of Scotland.  She manages a team of pharmacists and pharmacy technicians who deliver on studies sponsored by NHS GGC or co-sponsored with the University of Glasgow, as well as hosting around 400 CTIMPs across 4 research portfolios, covering all phases and therapeutic areas.  She has practised as a clinical pharmacist in the areas of oncology, critical care and anaesthetics.